HAYDEN DONALD J JR

Director at AMICUS THERAPEUTICS, INC. · on record since May 30, 2007
Director at INSMED Inc · on record since Dec 7, 2010
EVP and President, Americas at BRISTOL MYERS SQUIBB CO · on record since Sep 12, 2003
Director at Theseus Pharmaceuticals, Inc. · on record since May 18, 2022
Director at Vitae Pharmaceuticals, Inc · on record since Sep 26, 2014
Director at REGENXBIO Inc. · on record since Sep 22, 2015

Insider trading activity of HAYDEN DONALD J JR

Transactions on record: 160; since Sep 12, 2003

Open-market buys: 7; $208.4K

Open-market sells: 34; $14.4M

Companies traded: 6; last filing Feb 14, 2024

Figures computed from official regulatory filings — .

Companies where HAYDEN DONALD J JR has traded

Theseus Pharmaceuticals, Inc.7 tx · $50K · Feb 14, 2024
REGENXBIO Inc.58 tx · $9.5M · Jun 2, 2020
INSMED Inc43 tx · $3.7M · Apr 11, 2019
AMICUS THERAPEUTICS, INC.24 tx · $2.1M · Jun 11, 2018
Vitae Pharmaceuticals, Inc21 tx · $1.9M · Oct 25, 2016
BRISTOL MYERS SQUIBB CO7 tx · $258.8K · Mar 3, 2005

Track record of HAYDEN DONALD J JR

Statistical track record

Free account

Open-market buys: 8

Last buy: Dec 30, 2022

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of HAYDEN DONALD J JR

Co-insiders of HAYDEN DONALD J JR

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Theseus Pharmaceuticals, Inc.Listing unverified	Feb 14, 2024	Other	-10,000	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Feb 14, 2024	OtherD (derivative)	-3,250	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Jun 13, 2023	AwardD (derivative)	3,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Jun 13, 2023	AwardD (derivative)	19,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Jan 3, 2023	Buy	9,900	5.00 USD	$49.5K	conv 53Cluster	SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Jan 3, 2023	Buy	100	5.00 USD	$500	conv 54ClusterFirst in 12mo	SEC
Theseus Pharmaceuticals, Inc.Listing unverified	May 18, 2022	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REGENXBIO Inc.Listing on record	Jun 2, 2020	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REGENXBIO Inc.Listing on record	Feb 12, 2020	Sell	-24,800	50.11 USD	$1.2M	Unusual size	SEC
REGENXBIO Inc.Listing on record	Feb 12, 2020	ExerciseD (derivative)	-24,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REGENXBIO Inc.Listing on record	Feb 12, 2020	Exercise	24,800	0.85 USD	$21.1K		SEC
REGENXBIO Inc.Listing on record	Feb 7, 2020	ExerciseD (derivative)	-2,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REGENXBIO Inc.Listing on record	Feb 7, 2020	Exercise	2,000	0.85 USD	$1.7K		SEC
REGENXBIO Inc.Listing on record	Feb 7, 2020	Sell	-2,000	50.00 USD	$100K		SEC
REGENXBIO Inc.Listing on record	Jan 21, 2020	Sell	-3,200	50.01 USD	$160K		SEC
REGENXBIO Inc.Listing on record	Jan 21, 2020	ExerciseD (derivative)	-3,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REGENXBIO Inc.Listing on record	Jan 21, 2020	Exercise	3,200	0.85 USD	$2.7K		SEC
REGENXBIO Inc.Listing on record	Jan 16, 2020	Exercise	30,000	0.85 USD	$25.5K		SEC
REGENXBIO Inc.Listing on record	Jan 16, 2020	ExerciseD (derivative)	-30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REGENXBIO Inc.Listing on record	Jan 16, 2020	Sell	-30,000	45.60 USD	$1.4M	Unusual size	SEC
REGENXBIO Inc.Listing on record	Jun 4, 2019	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INSMED IncListing on record	Apr 11, 2019	Exercise	6,286	3.03 USD	$19K		SEC
INSMED IncListing on record	Apr 11, 2019	Sell	-6,286	32.99 USD	$207.4K		SEC
INSMED IncListing on record	Apr 11, 2019	ExerciseD (derivative)	-6,286	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INSMED IncListing on record	Feb 27, 2019	ExerciseD (derivative)	-100	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Theseus Pharmaceuticals, Inc.Listing unverified	Feb 14, 2024	Other	-10,000	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Feb 14, 2024	OtherD (derivative)	-3,250	—	n/a (No price was disclosed in the filing)		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Jun 13, 2023	AwardD (derivative)	3,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Jun 13, 2023	AwardD (derivative)	19,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Jan 3, 2023	Buy	9,900	5.00 USD	$49.5K	conv 53Cluster	SEC
Theseus Pharmaceuticals, Inc.Listing unverified	Jan 3, 2023	Buy	100	5.00 USD	$500	conv 54ClusterFirst in 12mo	SEC
Theseus Pharmaceuticals, Inc.Listing unverified	May 18, 2022	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REGENXBIO Inc.Listing on record	Jun 2, 2020	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REGENXBIO Inc.Listing on record	Feb 12, 2020	Sell	-24,800	50.11 USD	$1.2M	Unusual size	SEC
REGENXBIO Inc.Listing on record	Feb 12, 2020	ExerciseD (derivative)	-24,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REGENXBIO Inc.Listing on record	Feb 12, 2020	Exercise	24,800	0.85 USD	$21.1K		SEC
REGENXBIO Inc.Listing on record	Feb 7, 2020	ExerciseD (derivative)	-2,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REGENXBIO Inc.Listing on record	Feb 7, 2020	Exercise	2,000	0.85 USD	$1.7K		SEC
REGENXBIO Inc.Listing on record	Feb 7, 2020	Sell	-2,000	50.00 USD	$100K		SEC
REGENXBIO Inc.Listing on record	Jan 21, 2020	Sell	-3,200	50.01 USD	$160K		SEC
REGENXBIO Inc.Listing on record	Jan 21, 2020	ExerciseD (derivative)	-3,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REGENXBIO Inc.Listing on record	Jan 21, 2020	Exercise	3,200	0.85 USD	$2.7K		SEC
REGENXBIO Inc.Listing on record	Jan 16, 2020	Exercise	30,000	0.85 USD	$25.5K		SEC
REGENXBIO Inc.Listing on record	Jan 16, 2020	ExerciseD (derivative)	-30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REGENXBIO Inc.Listing on record	Jan 16, 2020	Sell	-30,000	45.60 USD	$1.4M	Unusual size	SEC
REGENXBIO Inc.Listing on record	Jun 4, 2019	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INSMED IncListing on record	Apr 11, 2019	Exercise	6,286	3.03 USD	$19K		SEC
INSMED IncListing on record	Apr 11, 2019	Sell	-6,286	32.99 USD	$207.4K		SEC
INSMED IncListing on record	Apr 11, 2019	ExerciseD (derivative)	-6,286	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INSMED IncListing on record	Feb 27, 2019	ExerciseD (derivative)	-100	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC